Metis Global Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Metis Global Partners's MDT Position: Q2 2026 in Review
Metis Global Partners reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $456K and leaving 30,863 shares worth $2.41M. The position accounts for 0.05% of the portfolio, ranked #262.
Metis Global Partners first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.88M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Metis Global Partners held 30,863 shares of Medtronic worth $2.41M as of Q2 2026.
- Metis Global Partners sold 5,649 Medtronic shares in Q2 2026, an estimated $456K.
- Medtronic made up 0.05% of Metis Global Partners's portfolio in Q2 2026, its #262 holding.
- Metis Global Partners first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's Medtronic position peaked at $4.88M in Q3 2024.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.